Grace Halsey

Patients with asthma who did require hospitalization for SARS-CoV-2 infection were at greater risk for intubation and remdesivir treatment, a new study reports.

The landmark approval for the SGLT-2 inhibitor will open access to treatment for the ~ 3 million adults with heart failure with preserved ejection fraction.

In the PATH-BP study, use of acetaminophen 4g/day increased BP among patients with hypertension by nearly 5 mm Hg within 2 weeks of beginning the regimen.

t:slim X2 insulin pump users can now program or cancel bolus dosing with the secure t:connect mobile app already on their phones, says Tandem Diabetes Care.

In the majority of studies that reported racial/ethnic data, White participants were highly overrepresented and Black/Hispanic/all Other underrepresented.

US patients at high CV risk do not receive adequate evidence-based pharmacotherapy, according to large multisite cohort analysis.

Among persons who survived COVID-19, a new study found a 60% increased risk for any new mental health diagnosis during the year following infection.

Recommendations on hypertension management from the US Surgeon General's office are summarized for at-a-glance American Heart Month reading.

The CDC is inviting public feedback on updated recommendations for opioid prescribing for the first time since the controversial 2016 iteration.

The 2022 DSMES National Standards update focuses on reducing administrative burden on educators and improving person-centered care for patients.

The 50 states and DC are ranked by longest and shortest life expectancy at birth and at age 65 years and by the difference in life expectancy between men and women.

The 180-day sensor life doubles the period of continuous use and cuts in half the number of CGM removals and reinsertions, without loss of accuracy.

The 5-year cumulative relapse rate among early quitters was nearly 40% in a large international cohort of stroke patients, according to an abstract presented at ISC22.

Nearly two-thirds of persons aged younger than 50 years who had an acute ischemic stroke had obesity in a study presented at the 2022 International Stroke Conference.

Prior authorization-related delays in care have led to serious patient outcomes, including hospitalization, disability, even death, said one-third of physicians surveyed.

Higher daily step counts by women aged ≥65 years was associated with reduced risk for incident diabetes, an effect that was modified by the level of stepping intensity.

These 42 factors that affect blood glucose are listed in categories including food, activity, and biological influences. Perfect information to share with your patients with T2D.

Tirzepatide at 3 different doses significantly improved glycemic control and promoted weight loss when added to titrated insulin in patients with type 2 diabetes.

Use of SGLT2 inhibitor and GLP-1 RA therapy in patients with type 2 diabetes appears to confer hepatic protection when compared with use of DPP-4 inhibitors.

Greatest improvements in A1c, %TIR, and other glycemic parameters were seen in patients treated with ≤1 medication, in another challenge to current payer restrictions.

Vaccination against flu is the best protection from the infection according to 61% of US adults surveyed by NFID. How do the rest feel about the threat?

Integrating NAFLD as a diabetes complication to be addressed during routine cycles of care could reduce barriers to a NAFLD pathway in primary care, agreed focus group participants.

NYU endocrinologist Brian Levy, MD, offers perspective on keeping the transition from basal insulin to multiple daily injections as simple as possible for patient and provider.

The COVID-19 Omicron variant may cause milder disease than the Delta variant, but its rapid spread in Los Angeles County still singled out unvaccinated Angelinos.

Adverse events seen with resmetirom were similar across dose and placebo groups and there were "significant reductions" seen in liver fat, LDL-C, and ApoB.

Type 2 diabetes patients-and their PCPs-may have trouble moving to basal + mealtime insulin from basal insulin alone. Endocrinologist Brian Levy, MD, offers insights.

New data from the phase 3 NAVIGATOR trial demonstrate superior efficacy of tezepelumab to reduce asthma exacerbations in severe disease year round.

Known as BA.2, the new Omicron subvariant is now circulating at low levels in the US. What can you tell your patients? Here's what we know, now.

The psychiatrist-author of "Coping with COVID-19: The Mental, Medical, and Social Consequences of the Pandemic," talks frankly about the pandemic's long-term impact on American health.

Acting FDA Commissioner Janet Woodcock, MD, hopes the approval will help motivate more Americans to get vaccinated.